Literature DB >> 17314518

Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection.

Jakob Nilsson1, Sabine Kinloch-de-Loes, Anna Granath, Anders Sönnerborg, Li-Ean Goh, Jan Andersson.   

Abstract

OBJECTIVE: To study innate and adaptive immune responses in gut-associated lymphoid tissue (GALT) as well as peripheral lymphoid tissue (pLT) obtained from individuals with acute HIV-1 infection syndrome.
DESIGN: The expression of chemokines [regulated upon activation: normal T cell expressed/secreted (RANTES), macrophage-inflammatory protein (MIP) 1alpha/beta], cytokines (IL-1beta, TNF-alpha, IL-12, IL-4, IL-10, IL-2, IFN-gamma) and cytotoxic effector molecules (granzyme A, perforin) and cell marker (CD8) were analysed at the single cell level in GALT and pLT of patients experiencing acute HIV-1 infection (day -3 to 48 days from onset of acute symptoms).
RESULTS: Substantial pro-inflammatory immune responses (TNF-alpha, IL-1beta, IL-12) and expansion in the CD8 T-cell population were noted in both compartments compared with uninfected controls. This was associated with an early increased expression of beta-chemokines (RANTES, MIP-1alpha/beta) and granzyme, but not with an increase in the expression of perforin. The upregulation of IL-2, IL-12 and IL-4 was noted in both pLT and GALT, whereas IL-10 expression was mainly increased in GALT.
CONCLUSION: Taken together, these findings demonstrate that there was a broad and early immune activation in GALT and pLT during acute HIV-1 infection. The relative lack of perforin expression in both GALT and pLT, however, questions the functional efficacy of the observed immune activation in generating cytotoxic T cells that were able to eliminate HIV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314518     DOI: 10.1097/QAD.0b013e3280117204

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  35 in total

1.  Key Concepts in the Early Immunology of HIV-1 Infection.

Authors:  Basile Siewe; Alan Landay
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

2.  Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.

Authors:  Alice M Nyakeriga; Jun Ying; Norah J Shire; Carl J Fichtenbaum; Claire A Chougnet
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

3.  Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.

Authors:  Adriana A Byrnes; David M Harris; Sowsan F Atabani; Beulah P Sabundayo; Susan J Langan; Joseph B Margolick; Christopher L Karp
Journal:  J Leukoc Biol       Date:  2008-09-19       Impact factor: 4.962

4.  Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

Authors:  Edwin Leeansyah; Anupama Ganesh; Máire F Quigley; Anders Sönnerborg; Jan Andersson; Peter W Hunt; Ma Somsouk; Steven G Deeks; Jeffrey N Martin; Markus Moll; Barbara L Shacklett; Johan K Sandberg
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

5.  Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments.

Authors:  Hiromi Imamichi; Gerald Degray; Robin L Dewar; Peter Mannon; Michael Yao; Cheryl Chairez; Irini Sereti; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

Review 6.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

7.  Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.

Authors:  Malavika S Giri; Michael Nebozyhn; Andrea Raymond; Bethsebah Gekonge; Aidan Hancock; Shenoa Creer; Calen Nicols; Malik Yousef; Andrea S Foulkes; Karam Mounzer; Jane Shull; Guido Silvestri; Jay Kostman; Ronald G Collman; Louise Showe; Luis J Montaner
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.

Authors:  Sumathi Sankaran; Michael D George; Elizabeth Reay; Moraima Guadalupe; Jason Flamm; Thomas Prindiville; Satya Dandekar
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

9.  Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells.

Authors:  David Verhoeven; Sumathi Sankaran; Melanie Silvey; Satya Dandekar
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

Review 10.  The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.

Authors:  Claire Vandergeeten; Rémi Fromentin; Nicolas Chomont
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.